Edesa Biotech, Inc. SEC filings EDSA
Edesa Biotech, Inc. has 751 filings in SEC EDGAR's recent list, going back to Feb 3, 2012. Its latest annual report, Form ARS, was filed on Apr 3, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (officer or director change). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 3, 2026 | — |
| DEF 14A | Proxy statement | Apr 3, 2026 | May 27, 2026 |
| DEFA14A | Additional proxy material | Apr 4, 2025 | — |
| DEF 14A | Proxy statement | Apr 4, 2025 | May 28, 2025 |
| DEFA14A | Additional proxy material | Apr 5, 2024 | — |
| DEF 14A | Proxy statement | Apr 5, 2024 | Apr 3, 2024 |
| DEF 14A | Proxy statement | Mar 28, 2023 | Mar 13, 2023 |
| DEF 14A | Proxy statement | Apr 1, 2022 | May 18, 2022 |
| DEF 14A | Proxy statement | Mar 3, 2021 | Apr 22, 2021 |
| DEFA14A | Additional proxy material | Mar 24, 2020 | — |
| DEF 14A | Proxy statement | Mar 23, 2020 | May 13, 2020 |
| DEF 14C | Information statement | Oct 25, 2019 | Oct 22, 2019 |
| DEFA14A | Additional proxy material | May 8, 2019 | — |
| DEFM14A | Filing | Apr 18, 2019 | — |
| PREM14A | Filing | Mar 29, 2019 | Mar 29, 2019 |
| DEFA14A | Additional proxy material | Mar 8, 2019 | — |
| DEF 14A | Proxy statement | Feb 13, 2018 | Mar 27, 2018 |
| PRE 14A | Preliminary proxy statement | Feb 2, 2018 | Feb 2, 2018 |
| DEF 14A | Proxy statement | Feb 1, 2017 | Mar 23, 2017 |
| DEF 14A | Proxy statement | Jan 25, 2016 | Mar 17, 2016 |
| DEF 14A | Proxy statement | Sep 28, 2015 | Oct 29, 2015 |
| PRE 14A | Preliminary proxy statement | Sep 17, 2015 | Sep 17, 2015 |
| DEFA14A | Additional proxy material | Sep 15, 2015 | — |
| DEF 14A | Proxy statement | Jan 13, 2015 | Feb 12, 2015 |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EDSA (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- British Columbia, Canada
- Headquarters
- Toronto
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1540159
- Former names
- Stellar Biotechnologies, Inc. (until May 30, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.